Barrowcliffe Susan E.
Insider CIK 1664251 · AIMT General Manager, Europe
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2018-11-19 | 2018-11-21 | 40,000 | — | $0 | 53,400 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2018-11-19 | 2018-11-21 | 40,000 | $30.04 | $1.20M | 9,375 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2018-11-19 | 2018-11-21 | 40,000 | $3.02 | $120.8K | 49,375 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2018-03-04 | 2018-03-06 | 56,250 | — | $0 | 56,250 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2018-03-04 | 2018-03-06 | 9,375 | — | $0 | 9,375 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 75,000 | — | $0 | 93,400 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2018-01-02 | 2018-01-04 | 300 | $37.86 | $11.4K | 25,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2018-01-02 | 2018-01-04 | 24,400 | $37.12 | $905.7K | 600 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 75,000 | $3.02 | $226.5K | 75,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2018-01-02 | 2018-01-04 | 600 | $37.75 | $22.6K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2018-01-02 | 2018-01-04 | 599 | $37.78 | $22.6K | 50,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2018-01-02 | 2018-01-04 | 24,401 | $37.12 | $905.8K | 50,599 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2018-01-02 | 2018-01-04 | 24,700 | $37.13 | $917.1K | 25,300 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2017-09-25 | 2017-09-27 | 20,000 | — | $0 | 168,400 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2017-09-25 | 2017-09-27 | 20,000 | $3.02 | $60.4K | 20,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2017-09-25 | 2017-09-27 | 20,000 | $25.00 | $500.0K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2017-09-06 | 2017-09-07 | 15,167 | — | $0 | 188,400 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2017-09-06 | 2017-09-07 | 15,167 | $22.00 | $333.7K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2017-09-06 | 2017-09-07 | 15,167 | $3.02 | $45.8K | 15,167 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2017-09-05 | 2017-09-07 | 3,223 | — | $0 | 203,567 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2017-09-05 | 2017-09-07 | 3,223 | $3.02 | $9.7K | 3,223 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2017-09-05 | 2017-09-07 | 3,223 | $22.00 | $70.9K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2017-07-27 | 2017-07-31 | 500 | — | $0 | 206,790 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2017-07-27 | 2017-07-31 | 500 | $3.02 | $1.5K | 500 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2017-07-27 | 2017-07-31 | 500 | $22.00 | $11.0K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2017-07-25 | 2017-07-25 | 4,650 | — | $0 | 207,290 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2017-07-25 | 2017-07-25 | 4,650 | $3.02 | $14.0K | 4,650 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2017-07-25 | 2017-07-25 | 4,650 | $22.00 | $102.3K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2017-07-24 | 2017-07-25 | 500 | — | $0 | 211,940 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2017-07-24 | 2017-07-25 | 500 | $3.02 | $1.5K | 500 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2017-07-24 | 2017-07-25 | 500 | $22.00 | $11.0K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2017-07-21 | 2017-07-25 | 960 | — | $0 | 212,440 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2017-07-21 | 2017-07-25 | 960 | $22.00 | $21.1K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2017-07-21 | 2017-07-25 | 960 | $3.02 | $2.9K | 960 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2017-07-03 | 2017-07-06 | 15,000 | — | $0 | 213,400 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2017-07-03 | 2017-07-06 | 15,000 | $3.02 | $45.3K | 15,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2017-07-03 | 2017-07-06 | 15,000 | $20.26 | $303.9K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2017-02-24 | 2017-02-24 | 90,000 | — | $0 | 90,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2016-11-11 | 2016-11-15 | 20,000 | — | $0 | 228,400 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2016-11-11 | 2016-11-15 | 20,000 | $3.02 | $60.4K | 20,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2016-11-11 | 2016-11-15 | 20,000 | $25.00 | $500.0K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2016-11-08 | 2016-11-10 | 15,000 | — | $0 | 248,400 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | S Sale | 2016-11-08 | 2016-11-10 | 15,000 | $20.00 | $300.0K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2016-11-08 | 2016-11-10 | 15,000 | $3.02 | $45.3K | 15,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2016-02-26 | 2016-02-26 | 80,000 | — | $0 | 80,000 | SEC↗ |